Khaitan & Co and Quillon Partners advised on RPG Life Sciences’ transfer of its API (Active Pharmaceutical Ingredients) business into RPG Active Pharma as a going concern on a slump sale basis and investment by InvAscent.
RPG Life Sciences announced the execution of a Business Transfer Agreement for the transfer of the Company’s Active Pharmaceutical Ingredients (API) business to RPG Active Pharma Limited (RPG Active Pharma or RPGAP), a wholly owned subsidiary of RPG Life Sciences, as a going concern on a slump sale basis and the subsequent investment by private equity investor InvAscent.
The transaction involved the restructuring of RPG Group’s API business into a dedicated platform, RPG Active Pharma, to support its continued growth and expansion.
Khaitan & Co acted as legal counsel and structuring advisor to RPG Group on the transaction.
The core team consisted of Managing Partner Haigreve Khaitan, Partner Shishir Vayttaden, Partner Aditi Singhvi and Associate Bhaskar Vishwajeet.
The following teams assisted on the deal-
Real Estate: Partner Harsh Parikh, Principal Associate Rahul Agarwal and Associate Raghav Pareek.
Intellectual Property: Partner Nirupam Lodha, Senior Associate Toshani Mukherjee and Associate Rebecca Cardoso.
Quillon Partners provided legal counsel in connection with RPG Group’s investment transaction.
The deal reporting on this platform is based on the information received from law firms, and therefore, some details may be missing/incomplete. If your firm has not been credited for this deal, write to us at chanchal.makhija@thegreymatter.co.in mentioning your firm’s name, lawyers involved (including designation) and client represented.
